Search

everythinglearnresearchcommunity

for

Search:↓

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Topical ruxolitinib may help some skin conditions but needs more research for alopecia areata.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Topical ruxolitinib cream may help treat frontal fibrosing alopecia.

CTP-543 is generally safe for treating alopecia areata.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

Deuruxolitinib effectively improves hair regrowth in alopecia areata but requires monitoring for side effects.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Deuruxolitinib improves anxiety and depression in severe alopecia areata patients.

Deuruxolitinib effectively promotes hair regrowth in adults with alopecia areata.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Ruxolitinib treatment may cause eyelash growth.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Nanophytosomes can improve the delivery and effectiveness of herbal medicines like Rutin.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

A girl with Evans' syndrome had her low platelet count successfully treated with zanubrutinib.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Tretinoin cream successfully treated a woman's skin condition called Fox-Fordyce disease.

Trastuzumab may cause tufted hair folliculitis as a side effect.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Topical ruxolitinib and oral minoxidil together can regrow hair in certain types of hair loss.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.